LON:VENN - Venn Life Sciences Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started GBX 2.65 0.00 (0.00 %) (As of 05/23/2019 11:21 AM ET)Previous CloseGBX 2.65Today's RangeGBX 2.65 - GBX 2.6552-Week RangeGBX 1.45 - GBX 7.46VolumeN/AAverage Volume30,982 shsMarket Capitalization£1.89 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileChartInsider TradesHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Venn Life Sciences Holdings Plc, a clinical research organization, provides consulting and clinical trial services to pharmaceutical, biotechnology, and medical device companies in the United Kingdom, Ireland, France, the Netherlands, Germany, and Singapore. The company offers drug development planning and strategy services, including clinical feasibility assessment, project management, and in-licensing and technical due diligence; and early drug development services, such as drug candidate selection, CMC, non-clinical/pre-clinical development, clinical pharmacology, pharmacokinetics, and pharmacometrics and PK-PD modelling. It also provides clinical trial services comprising clinical feasibility assessment, project management, clinical and medical monitoring, biometrics, biostatistics, data management and databases integration, ISC/IDMC, RTSM, investigator initiated studies, and resourcing and recruitment. In addition, the company offers regulatory affairs and consulting, quality assurance, and legal services, as well as drug development training and courses. The company has a strategic collaboration with Open Orphan DAC for the clinical research and regulatory consulting for companies developing products under the auspices of the various Orphan Drug frameworks. The company was founded in 2012 and is headquartered in Dublin, Ireland. Receive VENN News and Ratings via Email Sign-up to receive the latest news and ratings for VENN and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange LON Industry Medical Care Sub-IndustryN/A SectorN/A Current SymbolLON:VENN Previous Symbol CUSIPN/A CIKN/A Webhttp://www.vennlifesciences.com/ Phone+44-28-90737900Debt Debt-to-Equity Ratio10.14 Current Ratio1.67 Quick Ratio1.67Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueGBX 15.60 per share Price / Book0.17Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees157 Outstanding Shares71,395,200Market Cap£1.89 million Next Earnings DateN/A OptionableNot Optionable Venn Life Sciences (LON:VENN) Frequently Asked Questions What is Venn Life Sciences' stock symbol? Venn Life Sciences trades on the London Stock Exchange (LON) under the ticker symbol "VENN." Has Venn Life Sciences been receiving favorable news coverage? News coverage about VENN stock has trended very negative on Thursday, according to InfoTrie. The research firm identifies negative and positive news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Venn Life Sciences earned a media sentiment score of -3.8 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the near future. Who are some of Venn Life Sciences' key competitors? Some companies that are related to Venn Life Sciences include Totally (TLY), Wellness and Beauty (WNB), Widecells Group (WDC), Agility Health (AHI), Amadeus It Group (AMS), Blvd Centers (CXV), Cambian Group (CMBN), CHAMPION PAIN C/SH SH (CPAI), Eviana Health (EHC), Medical Facilities (MFCSF), Premier Health Group (PHGI), Ramsay Health Care Limited Fully Paid Ord. Shrs (RMSYF), RHOEN-KLINIKUM/ADR (RKAGY), SONIC HEALTHCAR/S (SKHHY) and Sonic Healthcare (SKHCF). What other stocks do shareholders of Venn Life Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Venn Life Sciences investors own include Nielsen (NLSN), Biogen (BIIB), Arts-Way Manufacturing (ARTW), Adomani (ADOM), Adobe (ADBE), Achieve Life Sciences (ACHV), Allegiance Bancshares (ABTX), Scotgold Resources (SGZ), McBride (MCB) and Firestone Diamonds (FDI). Who are Venn Life Sciences' key executives? Venn Life Sciences' management team includes the folowing people: Mr. Anthony Richardson, CEO, Exec. Director & Company Sec. (Age 55)Dr. Christian Bernard Milla, COO & Director (Age 57) How do I buy shares of Venn Life Sciences? Shares of VENN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Venn Life Sciences' stock price today? One share of VENN stock can currently be purchased for approximately GBX 2.65. How big of a company is Venn Life Sciences? Venn Life Sciences has a market capitalization of £1.89 million. Venn Life Sciences employs 157 workers across the globe. What is Venn Life Sciences' official website? The official website for Venn Life Sciences is http://www.vennlifesciences.com/. How can I contact Venn Life Sciences? Venn Life Sciences' mailing address is 1 Berkeley Street, LONDON, W1J 8DJ, United Kingdom. The company can be reached via phone at +44-28-90737900. MarketBeat Community Rating for Venn Life Sciences (LON VENN)Community Ranking: 2.2 out of 5 ( )Outperform Votes: 70 (Vote Outperform)Underperform Votes: 92 (Vote Underperform)Total Votes: 162MarketBeat's community ratings are surveys of what our community members think about Venn Life Sciences and other stocks. Vote "Outperform" if you believe VENN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VENN will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/23/2019 by MarketBeat.com StaffFeatured Article: How to Use a Moving Average for Trading Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.